Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Healthcare Realty Trust Incorporated Common Stock (HR) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance

Healthcare Realty Trust Incorporated Common StockTrade
Ionis Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Healthcare Realty Trust Incorporated Common Stock vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Healthcare Realty Trust Incorporated Common Stock trades at $17 (market cap $5.90B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Healthcare Realty Trust Incorporated Common Stock pays a 5.57% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthcare Realty Trust Incorporated Common Stock for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.

HRIONS
Market Cap
$5.90B$7.04B
Volume
4,466,6102,977,440
Sector
Real EstateHealth
52-Week High
$21.87$86.50
52-Week Low
$16.34$42.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.29B$6.60B
Dividend Yield
5.57%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HR
100% Buy0% Sell
Avg holding period · 0 Days
IONS
100% Buy0% Sell
Avg holding period · 0 Days

About Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Incorporated is a real estate investment trust that owns and manages outpatient medical facilities and on-campus medical office buildings across US, leasing space to physician groups, hospitals, and health systems.

Read more on HR →

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →